Testosterone Replacement Linked to Lower Rates of Aggressive Prostate Cancer March 13, 2017 Men who receive testosterone replacement therapy (TRT) had an increased rate of favorable-risk prostate cancer compared to those who did not use the therapy, and a decreased rate of aggressive prostate cancer. The favorable risk disease may represent a detection bias in these patients, according to the researchers.Read more.Source: Cancer Network Prostate Cancer News
Men who receive testosterone replacement therapy (TRT) had an increased rate of favorable-risk prostate cancer compared to those who did not use the therapy, and a decreased rate of aggressive prostate cancer. The favorable risk disease may represent a detection bias in these patients, according to the researchers.Read more.Source: Cancer Network
